ISSN: 2320-480X
Manuscript Submission

The Journal of Phytopharmacology, 2015;4(1):5-8 DOI:10.31254/phyto.2015.4102

Research Article

In-vitro cholinesterase inhibitory activity of dry fruit extract of Phyllanthus emblica relevant to the treatment of Alzheimer’s disease

Kushal Biswas1 , Md. Ariful Islam1 , Tahmida Sharmin1 , Pulak Kumar Biswas1

1. Department of Pharmacy, Faculty of Science, University of Rajshahi, Rajshahi, Bangladesh

*Author to whom correspondence should be addressed.

Abstract


Alzheimer’s disease (AD), a common type of progressive neurodegenerative disease, is characterized by low level of neurotransmitter (acetylcholine), oxidative stress and neuro-inflammation in brain stream. Effective treatment strategies rely mostly on either enhancing the cholinergic function of the brain by stimulating the cholinergic receptors, improve the level of acetylcholine from being a breakdown by cholinesterase enzymes or induce antioxidant therapy and anti-inflammatory agents. Phyllanthus emblica fruits are well known for its antioxidant activities with a rich source of vitamin C and polyphenols. A crude methyl extract (CME) of dry fruit of P. emblica evaluated for acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitory activity by Ellman’s method and were found active in inhibiting AChE and BuChE with IC50 of 53.88 µg/ml and 65.12 µg/ml respectively, which strongly implies that that the CME of P. emblica is a rich source of AChE and BuChE inhibitors.

Keywords


Cholinesterase inhibitor, Phyllanthus emblica, Alzheimer’s disease, Acetylcholinesterase inhibitor, Antioxidant, Butyrylcholinesterase inhibitor.

Creative Commons (CC) License-

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY 4.0) license. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. (http://creativecommons.org/licenses/by/4.0/).

Copyright

Copyright © 2015 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0.

Technical Support

×